Pacific Biosciences:INVESTOR RELATIONS
INVESTOR RELATIONS
PacificBiosciencesofCalifornia,Inc.FirstQuarter2024EarningsConferenceCallMay9,2024at5:00PMEDT.Barclays26thAnnualGlobalHealthcare ...。其他文章還包含有:「AboutUs」、「PACB-PacificBiosciencesofCalifornia,Inc.」、「PacBio」、「PacBio台灣代理伯森生技」、「PacificBiosciences」、「PacificBiosciencesofCalifornia」、「PacificBiosciencesofCalifornia」、「PacificBiosciencestolayoff195employeesaspartofc...
查看更多 離開網站About Us
https://www.pacb.com
We create the world's most advanced sequencing systems to provide you the most complete and accurate view of genomes, transcriptomes, and epigenomes. Our ...
PACB-Pacific Biosciences of California, Inc.
https://www.moneydj.com
Pacific Biosciences of California, Inc. · 1305 O'brien Drive,Menlo Park,California 94025,United States Of America · 428,723,008 (2024/04/29) ...
PacBio
https://www.pacb.com
PacBio highly accurate long-read sequencing provides the most comprehensive view of genomes, transcriptomes, and epigenomes. Learn how SMRT sequencing ...
PacBio 台灣代理伯森生技
https://www.blossombio.com
Sequence with Confidence. Pacific Biosciences (PacBio) - PacBio 台灣代理伯森生技 PacBio 於2004 年在美國加州成立,其獨家開發的「單一分子即時定序(Single ...
Pacific Biosciences
https://en.wikipedia.org
Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene ...
Pacific Biosciences of California
https://hk.finance.yahoo.com
截止2022年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為USD。
Pacific Biosciences of California
https://hk.finance.yahoo.com
Pacific Biosciences (PACB) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Pacific Biosciences to lay off 195 employees as part of cost ...
https://www.medtechdive.com
Pacific Biosciences, which sells gene sequencing equipment, announced the layoffs on Thursday along with its first-quarter results, reporting a ...
Sequencing systems
https://www.pacb.com
PacBio is consistently working to further advance genomic sequencing systems to create a more diversified portfolio of platforms.
說明
https://en.wikipedia.org